心不全に対する看護師指導と多学科的自己管理プログラムの有効性:総括的な体系的レビュー
Pupalan Iyngkaran1,2, Taksh Patel3, Diana Asadi4
1Cardiology, University of Notre Dame, Sydney, NSW 2007, Australia.
Biomedicines
|August 28, 2025
まとめ
低射出率の心不全に対する看護師主導の慢性疾患自己管理 (CDSM) プログラムは,死亡率の改善を示さないが,再入院を減らし,生活の質を向上させる. さらなる研究が推奨されています.
科学分野:
- 心臓病科
- 公衆衛生
- 看護学 研究
背景:
- 慢性疾患の自己管理プログラム (CDSM) は,心不全のエジェクション分数減少 (HFrEF) のために推奨されます.
- HFrEFに対するCDSMの有効性に関する既存のエビデンスは混在しています.
- このレビューは,HFrEFの成人の看護師主導の多分野CDSM介入に焦点を当てています.
研究 の 目的:
- HFrEF の成人における 閉塞性心不全 (CHF) に関するCDSMの体系的なレビューから得られた証拠を統合する.
- 医療従事者が主導する多分野CDSMの効果を批判的に評価する.
- 死亡率,再入院,生活の質,自己管理行動への影響を評価する.
主な方法:
- PRISMA 2020とAMSTAR-2のガイドラインに沿った体系的なレビュー.
- 複数のデータベース (MEDLINE,Embase,CINAHL,Cochrane Library) で2012年から2024年にかけて出版されたレビューを検索した.
- HFrEF患者に対するCDSM介入の体系的なレビューが含まれています.
主要な成果:
- 高品質のレビュー22件を含む60件の研究を分析した.
- 死亡率の利益に関する限られた不一致な証拠.
- 中等から高い確実性の証拠は,看護師主導のCDSMが病院再入院率と健康関連生活の質 (HRQoL) を改善することを示している.
- 自己管理行動の改善 (例えば,薬の遵守,症状のモニタリング) が頻繁に報告されました.
結論:
- 看護師主導のCDSM介入は,HFrEF患者の再入院を一貫して減少させ,HRQoLを改善します.
- 死亡率の利得に関する証拠は,まだ定かではありません.
- 将来の研究は 標準化された結果,経済的な評価,患者中心の,文化に合わせたアプローチに焦点を当てるべきです.
関連する概念動画
01:30Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
01:30Heart Failure VII: Nursing Interventions
139
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
139
01:28Mitral Regurgitation IV: Nursing Management
80
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
80
01:29Cardiomyopathy VI: Nursing Management
32
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
32
01:21Rheumatic Heart Disease III: Medical Management
31
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
31
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505